July 2016 Analysis

Industry Trend Analysis - Increased Outsourcing Requirements Changing CRO Role - JULY 2016

The evolving big pharma model is catalysing deep shifts within the CRO industry, with a move towards closer collaborative relationships. Whilst CROs initially attempted to draw in big pharma partnerships though size advantages, innovation is now becoming increasingly key. CROs that offer drug discovery solutions based on data-driven platforms will be of particular interest.